Efficacy and Safety of Insulin Glulisine in Intensive Insulin Therapy: Bolus Insulin Adjust Nice Control by apiDRA Study (BANDRA Study)
Read full paper at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53238#.VLh24MnQrzE Author(s) Yukihiro Bando * , Kousuke Shima , Keiko Aoki , Hideo Kanehara , Azusa Hisada , Kazuhiro Okafuji , Daisyu Toya , Nobuyoshi Tanaka Affiliation(s) Department of Internal Medicine, Fukui-ken Saiseikai Hospital, Fukui, Japan . ABSTRACT Background: Treatment for postprandial glycemia using rapid-acting insulin analogues sometimes resulted in preprandial hypoglycemia or weight gain. Objective: This study evaluated the efficacy and safety of switching bolus insulin from insulin lispro (Lis) to insulin glulisine (Glu) in patients with inadequately controlled diabetes on intensive insulin therapy with Lis and glargine (Gla). Methods: Seventy-two outpatients with inadequate glycemic control (glycated hemoglobin [HbA1c] ≥7.0%, glycated albumin [GA] ≥20%) on intensive insulin therapy comprising Lis and Gla for ≥24 weeks were enrolled. We switch...